Mobiflexi in the pitch format, and what an investor would ask
A joint supplement on the investor sofa is not an enthusiasm test but an arithmetic one: what a bottle costs, who is still there in week six, and why nothing of it sits on a shelf. The sums are here, objections included.
Why a joint supplement suits this format at all
The format is old and its logic older: ninety seconds for the founder, then the questions. A glucosamine bottle rarely draws applause; it draws arithmetic — acquisition cost, repeat rate, margin after delivery.
With Mobiflexi the arithmetic is interesting because the product is not in retail. Ask about shelf space and the answer is not distribution but direct selling: three bundles, a subscription, thirty days to change your mind, and no wholesaler taking a cut.
Investor questions and the answer the pitch has to give
| What an investor asks | The honest answer | Why the question comes |
|---|---|---|
| Why not retail | Direct through the manufacturer's own shop, no pharmacy and no supermarket margin | Shelf space takes 25 to 40 per cent of the price |
| Why three bundles | £49.95 single, £39.97 a bottle on two, £36.65 on the 90-day pack | Discounting the course length, not the quantity, keeps the customer longer |
| How far one bottle goes | Thirty daily doses, one capsule a day | It sets the reorder rhythm and the cash cycle |
| What entry costs | £49.95 plus £4.95 delivery, so £54.90 | The dearest step per day and the commonest place to leave |
| What holds customers | A 90-day course, noticeable effect usually from week six, 30-day money-back | A subscription with no effect window cancels by week five |
| Why not on Amazon UK | No direct shop there, so price control stays with the manufacturer | Marketplaces force discounts and give no address file |
Unit economics: what a bottle actually costs in the tank
Three bottles at the struck-through £69.95 come to £209.85. The 90-day pack is listed at £109.95, so £99.90 off — 47.6 per cent, or £1.22 a day. A single bottle is £1.67, or £1.83 with the £4.95 delivery; two land at £1.33.
An investor runs it back the other way. Out of £36.65 per bottle go the branded raw materials, the capsule, the carton and the last mile. What is left pays for acquiring the customer, not for making the product, and the second order is where the profit is. Hence the daily price as the pitch argument rather than the discount: £1.22 against £1.83 is a claim about habit, and habit is what a subscription buys.
What argues against it
- No shelf, nothing to hold People who cannot hold the packet order reluctantly. A pitch lives on demonstration; capsules demonstrate badly.
- The effect arrives late Six weeks to a noticeable change, four weeks to a cancellation. That gap is the weak point of every subscription here.
- No independent price anchor Without a marketplace listing there is nothing to compare against. The struck-through £69.95 is the only reference, and the seller sets it.
- The pre-ticked subscription The business model sits in small print. A shark asks about churn in month two, not about sign-ups.
- No defence worth the name Branded materials such as UC-II and Meriva help credibility, not competition: any formulator orders the same ones.
The retention argument nobody wins in that studio
The founder's side
Anyone who takes three months stays far longer than someone buying one bottle. £109.95 is a different commitment from £49.95, and whoever makes it reorders when stiffness returns.
The investor's side
Sales volume proves nothing about loyalty. Without a cohort curve per month, bundle choice is only an average, and averages sit well in a deck.
How this pitch most likely ends
Realistically an offer at a modest valuation. The margin in direct selling is respectable, but scaling is costly: every customer is bought individually, and British search traffic for joint relief is no cheap auction.
The next move would be retail, which is also the move that damages the pricing logic. While Mobiflexi stays off the shelf at Boots the sums hold; an investor with pharmacy relationships would contradict them.
Order Mobiflexi today
Order right here — the bundle price you were shown is the price you pay.
Order Mobiflexi now from £36.65 per bottle · Price valid until 2026-11-30Current Mobiflexi bundles
Three sizes, identical formula. The price per bottle falls as the supply lengthens — which is why most orders go for the 90-day pack.
What Mobiflexi customers report
Customer comments exactly as they appear here — name, age and town included.
